NCT03807297View on ClinicalTrials.gov

TIVA vs Inhalational Mode of Anaesthesia

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

December 30, 2019

Conditions
Anesthesia Awareness
Interventions
DRUG

Injection dexmedetomidine

alpha 2 a agonist used for sedation, analgesia

DRUG

Injection, Propofol, 10 Mg

non barbiturate type of intravenous anaesthetic drug

OTHER

sevoflurane

inhalational anaesthetic agent

OTHER

nitrous oxide

inhalational anaesthetic agent

Trial Locations (1)

110085

Rajiv Gandhi Cancer Institute and Research Centre, New Delhi

All Listed Sponsors
lead

Rajiv Gandhi Cancer Institute & Research Center, India

OTHER

NCT03807297 - TIVA vs Inhalational Mode of Anaesthesia | Biotech Hunter | Biotech Hunter